US Agency Cuts Millions in Health Research Funding

The Agency for Healthcare Research and Quality (AHRQ) has halted funding for numerous active research grants, impacting an estimated 150 projects and totaling $229 million. Researchers were notified via letters stating the agency was adjusting its award portfolio to better prioritize resources, mentioning patient safety, antibiotic resistance, and digital health tools as key areas. However, many scientists found their work already aligned with these priorities, and they were not provided with specific reasons for the discontinuation of their multiyear awards.

This sudden cessation of funding has left researchers in a precarious position, with many scrambling to find alternative sources of support from their institutions, private foundations, or other federal avenues like the National Institutes of Health. The AHRQ's move follows a period of staff reductions and a decline in grantmaking. For many, the discontinued grants were crucial for advancing health innovations, from improving kidney care and asthma treatments to studying the financial impact of COVID-19 and addressing substance abuse in primary care settings. The agency maintains that these were not terminations but rather a decision not to award continued funding, based on the director's assessment of the federal government's best interests.